Genpact CEO Suggests AI May Reduce IT Workload and Employment Growth
Fanatics Secures FIFA Collectibles License Faces Scrutiny Over Market Dominance
Alibaba Unveils NextGeneration Zhenwu AI Chip and Large Language Model to Bolster Cloud and AI Ambitions
Dow Surges 600 Points SP 500 and Nasdaq Rally as Oil Declines and Bond Yields Retreat Ahead of Nvidia Earnings
Equity Residential Emerges as a Leading Residential REIT Amid Resilient Rental Demand
South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest
OCSL Q1 2026 Earnings EPS Surpasses Estimates as Portfolio Remains Resilient
CISS Q3 2025 Earnings Loss Per Share of 058 as Shipping Headwinds Persist Stock Declines 339
MBIN Q1 2026 Earnings EPS Beat of 502 Surprises Analysts Yet Stock Declines
Pulmonx Corporation LUNG Q1 2026 Earnings NarrowerThanExpected Loss Keeps Sentiment Positive
VBNK Q1 2026 Earnings VersaBank Posts BottomLine Miss as Interest Income Pressures Persist
IBOC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement
Focus Universal Inc FCUV Faces Selling Pressure Tests Key Support at 075
Quanex Building Products NX Surges Over 3 as Housing Sector Sentiment Improves
Linkage Global Inc LGCB Consolidates Near Key Support Is a Breakout Brewing
Cosmos Health COSM Slips to 026 Testing Key Support Amid Downside Pressure
PCAPW Plunges 17 as Warrants Test Support at 028
Argan Inc AGX Q1 2026 Earnings EPS Surges 737 Above Estimates Shares Climb Nearly 2
Nextpower Inc NXT Q1 2026 Earnings EPS Beats Estimates by 1316 Stock Jumps 78
BioAge Labs Q1 2026 Earnings EPS Beat on Lower Loss PreRevenue Stage Continues
CVGI Q1 2026 Earnings EPS Beat Delivers Positive Surprise Amid Revenue Disclosures
TERN Q4 2025 Earnings Narrower Than Expected Loss as Pipeline Progress Continues
L3Harris Q1 2026 Earnings EPS Beat Drives Positive Market Response Despite Limited Revenue Disclosure
Metas New Forum App Pressures Reddit Shares Drop Nearly 6
Uranium Royalty Corp UROY Q1 2026 Earnings EPS Turns Positive Topping Estimates by 199 Stock Slips 3
Relmada Therapeutics RLMD Edges Higher as Stock Holds Above Key Support